Generic Drugs – Physician Perspective – Thematic Intelligence

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Reasons to buy the Generic Drugs – Physician Perspective thematic intelligence report:

  • Assess healthcare professionals’ attitudes towards generic drugs prescription.
  • Better understand the barriers to the production and uptake of generic medicines.
  • Capture physicians’ opinions on generics substitution.
  • Better understand patients’ preferences.
  • Assess past and future generics uptake.
  • Gain a better understanding of cost consideration when prescribing drugs.
  • Explore the differences across markets.

How is our Generic Drugs – Physician Perspective report unique from other reports in the market?

  • This report combines information obtained from secondary sources and primary research with physicians from the 7MM. Polls from the readers of the Pharmaceutical Technology website are also included in the report.
  • The report examines physician perception of generic medicines and provides insights into generics uptake, substitution patterns, and use across the seven major pharmaceutical markets.
  • The report highlights the key players in the generic space and includes generics market size as well as growth forecast.

We recommend this valuable source of information to anyone involved in: 

  • ​Pharmaceutical/Biotech/Drug Manufacturing Industries (Big Pharma, Small Biotech, Start-ups, etc.),
  • Pharmaceutical Industry Suppliers (e.g., Consulting Companies, CMOs, CDMOs, CROs, Technology Vendors)
  • Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
  • Pharma Manufacturers/Distributors (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease)
  • Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organizations
  • Healthcare Organizations (HTA Bodies, Reimbursement Groups and Payers, Government Healthcare Organizations)
  • Clinical Research Organizations (CROs)

To Get a Snapshot of the Generic Drugs Thematic Report

Download a Free Report Sample

Generic Drugs Thematic Intelligence Report Overview

The report suggests that US physicians prescribed more generic drugs to more than 60% of its patients when compared to their counterparts in the five major European markets (France, Germany, Italy, Spain, and the UK). Italy had the lowest number recorded in the surveyed countries.

Even though physicians and pharmacists play a crucial role in drug choice, patient preferences should not be ignored. When patients have more information about their disease treatment, better outcomes can be achieved.

Many healthcare professionals (HCPs) believe that the adoption of generics will further increase in the next five years because of the growing penetration of generic drugs especially in more advanced markets. Therefore, they support substituting brand-name drugs with generic medicines. HCPs also opine that they would prefer to use branded drugs for their patients if cost was not the main factor.

The ‘generic drugs – physician perspective’ thematic intelligence report assesses the healthcare professionals’ attitudes towards generic drug prescriptions. It gives an understanding of the physician’s perception of generic medicines and the patient’s preferences. The report also explores the physicians’ perception of the use of generic drugs across the seven major pharmaceutical markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

Key Countries ·       The US

·       France

·       Germany

·       Italy

·       Spain

·       The UK

·       Japan

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Generic Drugs – Current and Future Uptake

The US: Many HCPs in the US confirmed that they prescribe generic drugs to more than 61% of their patients. As the demand for drugs is increasing, governments are exerting pressure on doctors to prescribe cheaper generic medicines.

France: French physicians also indicated a strong uptake in generics use during the past five years and expected a further increase in the future. More than 34% of French HCPs reported using generic drugs. Physicians also confirmed the increasing trend in generic drug use during the past five years, and more than 60% of the survey respondents believed that generic uptake would increase in the next five years as well. This is the highest reported number across the surveyed countries.

Generic Drugs – Current and Future Uptake – The US

Generic Drugs - Current and Future Uptake – The US

Buy the Full Report for More Insights on the Current and Future Uptake of Generic Drugs

Download a Free Sample Report

Generic Drugs – Physician’s Perspective

Physicians’ perceptions can also significantly influence patient choices. The countries covered to know the physician’s perspective towards generic evaluated here include the US, 5EU, and Japan.

Japan: The uptake of generic drugs in Japan has been slower. However, ongoing government initiatives are helping to increase the utilization of generic medicines in this market. A significant percentage of physicians in Japan agreed that patients prefer branded drugs over generics. This common finding across all countries researched suggests that governments and physicians may need to engage more in patient education to address the patients’ misconceptions.

Buy the Full Report for More Insights on the Physician’s Attitude towards Generic Drugs

Download a Free Sample Report

Key Highlights

  • Generic drugs provide a good opportunity to increase efficiency in pharmaceutical spending.
  • Patient and physician education on generics is necessary to boost generics uptake.
  • Generic drug penetration has reached its zenith in most of the advanced pharmaceutical markets.

Frequently asked questions

Generic Drugs – Physician Perspective – Thematic Intelligence thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Generic Drugs – Physician Perspective – Thematic Intelligence was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Generic Drugs – Physician Perspective – Thematic Intelligence in real time.

  • Access a live Generic Drugs – Physician Perspective – Thematic Intelligence dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.